Nuvectis Price To Sales Ratio vs Income Quality Analysis
| NVCT Stock | USD 5.04 0.24 4.55% |
Nuvectis Pharma financial indicator trend analysis is infinitely more than just investigating Nuvectis Pharma recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nuvectis Pharma is a good investment. Please check the relationship between Nuvectis Pharma Price To Sales Ratio and its Income Quality accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvectis Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Nuvectis Stock please use our How to Invest in Nuvectis Pharma guide.
Price To Sales Ratio vs Income Quality
Price To Sales Ratio vs Income Quality Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nuvectis Pharma Price To Sales Ratio account and Income Quality. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Nuvectis Pharma's Price To Sales Ratio and Income Quality is -0.64. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Income Quality in the same time period over historical financial statements of Nuvectis Pharma, assuming nothing else is changed. The correlation between historical values of Nuvectis Pharma's Price To Sales Ratio and Income Quality is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of Nuvectis Pharma are associated (or correlated) with its Income Quality. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Quality has no effect on the direction of Price To Sales Ratio i.e., Nuvectis Pharma's Price To Sales Ratio and Income Quality go up and down completely randomly.
Correlation Coefficient | -0.64 |
| Relationship Direction | Negative |
| Relationship Strength | Weak |
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Nuvectis Pharma stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Nuvectis Pharma sales, a figure that is much harder to manipulate than other Nuvectis Pharma multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Income Quality
An assessment of the sustainability of a company's earnings over time, considering factors like revenue source diversification and cost structure.Most indicators from Nuvectis Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nuvectis Pharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvectis Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Nuvectis Stock please use our How to Invest in Nuvectis Pharma guide.Enterprise Value is likely to gain to about 116.1 M in 2024, whereas Selling General Administrative is likely to drop slightly above 4.6 M in 2024.
| 2010 | 2022 | 2023 | 2024 (projected) | Interest Income | 4K | 149K | 475K | 498.8K | Net Interest Income | 4K | 149K | 475K | 498.8K |
Nuvectis Pharma fundamental ratios Correlations
Click cells to compare fundamentals
Nuvectis Pharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Nuvectis Stock Analysis
When running Nuvectis Pharma's price analysis, check to measure Nuvectis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nuvectis Pharma is operating at the current time. Most of Nuvectis Pharma's value examination focuses on studying past and present price action to predict the probability of Nuvectis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nuvectis Pharma's price. Additionally, you may evaluate how the addition of Nuvectis Pharma to your portfolios can decrease your overall portfolio volatility.